Molecule Assessment
Evaluate molecular characteristics, concentration, stability, permeability, and administration requirements before formulation development.
PP-01 — Oromucosal Platform
PERMEAPULSE™️ OROMUCOSAL DELIVERY TECHNOLOGY
Your molecule.Designed fororomucosal delivery.
Fig. 01Oromucosal formulation platform
- 01Sublingual administrationA fine mist is delivered beneath the tongue
- 02Mucosal retentionDesigned to increase the amount of time the formulation remains in contact with the mucosal surface
- 03Permeation supportFormulation strategies are designed to support movement across the oral epithelium
- 04Molecular stabilizationControlled formulation conditions can be tailored to help maintain active-ingredient integrity
Sublingual anatomy — thin mucosal tissue with a rich underlying blood supply provides an alternative pathway for oromucosal delivery.
Built for commercial developmentFrom molecule assessment
From molecule assessment
to finished formulation.
Different molecules present different delivery challenges. PermeaPulse™ formulations can be developed around molecular characteristics, concentration, stability, pH, permeability profile, residence time, and intended administration site.
Formulation Development
Develop a molecule-specific environment around retention, permeability, pH, stability, and the intended administration site.
Scientific Characterization
Finished formulations can be evaluated using appropriate analytical and pharmacokinetic studies rather than assuming performance.
Scale-Up
Translate the optimized formulation toward repeatable finished-product production and commercial development.
Scientific validationPerformance should be measured.
Performance should be measured.
Not assumed.
Oromucosal administration does not automatically produce systemic exposure equivalent to injection or other established delivery routes. Absorption can vary depending on the molecule, formulation, and individual physiology.
- Absorption
- Bioavailability
- Time to Peak Concentration
- Maximum Concentration
- Overall Systemic Exposure
- Duration of Exposure
Pharmacokinetic studies can be used to scientifically characterize the performance of individual formulations.
Why it's different
Why the same active ingredient works better under the tongue.
A swallowed pill has to survive the stomach before it can work. PermeaPulse absorbs directly through the lining of the mouth, so more of the active ingredient gets where it needs to go.
A swallowed pill
Broken down in digestionSwallowed as a pill
→
Stomach acid and enzymes break it down
→
Little survives to the bloodstream
PermeaPulse, under the tongue
Skips the stomachOne spray under the tongue
→
Absorbs through the blood-rich lining of the mouth
→
Delivered straight to the bloodstream
Same active ingredient, delivered without a needle and without losing it to digestion.
Four things happen at the surface of the mouth.
Purpose-built. Science-driven. Designed for advanced drug delivery.
Designed to increase the amount of time a formulation remains in contact with the mucosal surface.
Designed to support movement of active molecules across the oral barrier.
Helps maintain the integrity of the active ingredient throughout formulation, storage, and administration.
Supports the integrity and usability of multi-dose finished products.
03 / Routes
Where the molecule enters changes everything.
PermeaPulse is built around the oral mucosa, the tissues of the mouth that offer an alternative to the digestive route.
Conventional oralCapsules, tablets, swallowed liquids travel through the stomach and gut, where acid, enzymes, and first-pass metabolism can break much of it down.
SublingualBeneath the tongue. Thin, blood-rich tissue that, for suitable molecules, can absorb relatively quickly through the oral mucosa.
BuccalAlong the inner cheek. A stable surface well-suited to formulations designed to stay in contact with the mucosa for longer.
04 / Platform
Built per molecule. Measured, not assumed.
Molecular size, structure, stability, and permeability all affect whether a molecule suits oromucosal delivery. Each formulation is developed around the molecule, then its performance is measured.
Characterized by PK study
AbsorptionMeasured
BioavailabilityMeasured
Time to peakTmax
Peak concentrationCmax
Overall exposureAUC
DurationMeasured
Oromucosal administration does not automatically match injection or other established routes, and absorption varies by molecule, formulation, and individual physiology. Finished formulations are evaluated individually.
05 / FAQStraight
Straight
answers.
What does "under the tongue" actually do?
The tissue beneath the tongue is thin and rich in blood vessels, so an active ingredient placed there can absorb directly into the bloodstream instead of being swallowed and broken down in the stomach.
How is this different from a pill?
A swallowed pill passes through the stomach and gut, where acid, enzymes, and first-pass metabolism break much of it down before it works. PermeaPulse absorbs through the lining of the mouth and skips the stomach.
Does every active ingredient work with the technology?
Unfortunately no, and we are very transparent about it. A molecule's size, structure, stability, and permeability all affect whether it suits oromucosal delivery. PermeaPulse is a platform, not one fixed formula, and we evaluate each molecule.
How do you know it works?
Each finished formulation is characterized with pharmacokinetic studies measuring absorption, bioavailability, time to peak, peak concentration, exposure, and duration. We measure performance rather than assume it, and results vary by molecule.
Is it safe?
The technology delivers across the body's own mucosal tissues, and permeation enhancement is designed to be temporary and supportive rather than forceful. Products can include antimicrobial protection for multi-dose use. End-use safety and compliance rest with the brand bringing the finished product to market.
Can it be used for compounding pharmacies?
Yes. Because PermeaPulse is a platform adaptable to individual molecules, it can be applied wherever oromucosal delivery is needed, including pharmacies, labs, and medical practices.
06 / The lineup
Formulations, grouped by route.
Listed by their active ingredients so you know exactly what you are getting. For business and wholesale evaluation, not for direct-to-consumer sale.
Drops / Sublingual16 formulations
01Sermorelin + Ipamorelin
02Reta
03Tirz
04CJC-Ipamorelin
05BPC-157
06BPC-157 / TB-500
07GLOW
08KLOW
09NAD
10GHK-Cu
11SS-31
12Kisspeptin
13Dihexa / Selank / Semax
14Thymosin Alpha-1 + KPV
15MOTS-C
16ARA-290
Intranasal4 formulations
01Selank / Semax / DSIP
02Epitalon
03Thymosin Alpha-1 / KPV
04NAD+
Have a molecule in mind? PermeaPulse develops molecule-specific formulations on the platform.
07 / Wholesale
Built into your product line.
Available wholesale for pharmacies, labs, medical practices, manufacturers, and distributors who want a proven oromucosal platform in their own products.
BULK SUPPLY
Wholesale volumes for high-volume partners
MULTI-SKU
Apply the platform across your catalog
CUSTOM FORMULATION
Molecule-specific development, built for you
Not the right volume? We will point you to a partner who is.
Develop with PermeaPulse™
Have a molecule in mind?
Tell us what you are developing. Our team can begin by reviewing the active ingredient, target concentration, intended application, and formulation requirements.
09 / Discuss your molecule
Tell us about the active ingredient you are developing.
Our team can begin by reviewing the molecule, target concentration, intended administration route, and formulation requirements.
This form is a visual placeholder. Submissions route to the PermeaPulse team once hosting is configured.